BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35651878)

  • 21. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in
    Palomäki A; ; Palotie A; Koskela J; Eklund KK; Pirinen M; ; Ripatti S; Laitinen T; Mars N
    Ann Rheum Dis; 2021 Dec; 80(12):1530-1536. PubMed ID: 34344703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
    Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
    Adegunsoye A; Vij R; Noth I
    Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.
    Wei R; Li C; Zhang M; Jones-Hall YL; Myers JL; Noth I; Liu W
    Transl Res; 2014 May; 163(5):494-502. PubMed ID: 24434656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset.
    McDermott G; Gill R; Gagne S; Byrne S; Huang W; Cui J; Prisco L; Zaccardelli A; Martin L; Kronzer VL; Moll M; Cho MH; Shadick N; Dellaripa PF; Doyle T; Sparks JA
    Rheumatology (Oxford); 2022 Nov; 61(12):4915-4923. PubMed ID: 35289841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MUC5B expression and location in surfactant protein C mutations in children.
    Liptzin DR; Watson AM; Murphy E; Kroehl ME; Dishop MK; Galambos C; Evans CM; Schwarz MI; Deterding RR; Schwartz DA
    Pediatr Pulmonol; 2015 Dec; 50(12):1270-6. PubMed ID: 25858779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.
    Zhu QQ; Zhang XL; Zhang SM; Tang SW; Min HY; Yi L; Xu B; Song Y
    Medicine (Baltimore); 2015 Oct; 94(43):e1901. PubMed ID: 26512610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.
    Peljto AL; Steele MP; Fingerlin TE; Hinchcliff ME; Murphy E; Podlusky S; Carns M; Schwarz M; Varga J; Schwartz DA
    Chest; 2012 Dec; 142(6):1584-1588. PubMed ID: 22576636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MUC5B and Idiopathic Pulmonary Fibrosis.
    Yang IV; Fingerlin TE; Evans CM; Schwarz MI; Schwartz DA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S193-9. PubMed ID: 26595739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis.
    Lewandowska KB; Szturmowicz M; Lechowicz U; Franczuk M; Błasińska K; Falis M; Błaszczyk K; Sobiecka M; Wyrostkiewicz D; Siemion-Szcześniak I; Bartosiewicz M; Radwan-Röhrenschef P; Roży A; Chorostowska-Wynimko J; Tomkowski WZ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.
    Schwartz DA
    Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S192-S197. PubMed ID: 30431344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MUC5B promoter polymorphism and pulmonary fibrosis.
    Zhang GY; Liao T; Gao WY
    N Engl J Med; 2011 Jul; 365(2):178; author reply 178-9. PubMed ID: 21751917
    [No Abstract]   [Full Text] [Related]  

  • 34. The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering
    Zhang Q; Wang Y; Qu D; Yu J; Yang J
    Biomed Res Int; 2019; 2019():9712464. PubMed ID: 31309122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.
    Volkmann ER; Tashkin DP; Roth MD; Li N; Charles J; Mayes M; Kim G; Goldin J; Pourzand L; Clements PJ; Furst DE; Khanna D; Elashoff RM; Assassi S
    Semin Arthritis Rheum; 2020 Oct; 50(5):963-967. PubMed ID: 32906032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MUC5B promoter polymorphism and interstitial lung abnormalities.
    Hunninghake GM; Hatabu H; Okajima Y; Gao W; Dupuis J; Latourelle JC; Nishino M; Araki T; Zazueta OE; Kurugol S; Ross JC; San José Estépar R; Murphy E; Steele MP; Loyd JE; Schwarz MI; Fingerlin TE; Rosas IO; Washko GR; O'Connor GT; Schwartz DA
    N Engl J Med; 2013 Jun; 368(23):2192-200. PubMed ID: 23692170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism.
    Chung JH; Peljto AL; Chawla A; Talbert JL; McKean DF; Rho BH; Fingerlin TE; Schwarz MI; Schwartz DA; Lynch DA
    Chest; 2016 May; 149(5):1215-22. PubMed ID: 26836909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort.
    Wang H; Zhuang Y; Peng H; Cao M; Li Y; Xu Q; Xin X; Zhou K; Liang G; Cai H; Dai J
    Sci Rep; 2019 Oct; 9(1):15307. PubMed ID: 31653936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.
    Wang N; Zhang Q; Jing X; Guo J; Huang H; Xu Z
    Med Sci Monit; 2020 Mar; 26():e920137. PubMed ID: 32142504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A
    Verma A; Minnier J; Wan ES; Huffman JE; Gao L; Joseph J; Ho YL; Wu WC; Cho K; Gorman BR; Rajeevan N; Pyarajan S; Garcon H; Meigs JB; Sun YV; Reaven PD; McGeary JE; Suzuki A; Gelernter J; Lynch JA; Petersen JM; Zekavat SM; Natarajan P; Dalal S; Jhala DN; Arjomandi M; Gatsby E; Lynch KE; Bonomo RA; Freiberg M; Pathak GA; Zhou JJ; Donskey CJ; Madduri RK; Wells QS; Huang RDL; Polimanti R; Chang KM; Liao KP; Tsao PS; Wilson PWF; Hung AM; O'Donnell CJ; Gaziano JM; Hauger RL; Iyengar SK; Luoh SW;
    Am J Respir Crit Care Med; 2022 Nov; 206(10):1220-1229. PubMed ID: 35771531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.